Tech-Enabled Health in Cardiovascular Disease

Cardiovascular diseases not only pose significant health challenges but also place a considerable financial strain on healthcare systems worldwide. With the global median age steadily rising and an increase in the prevalence of cardiovascular diseases, there is an urgent need for innovative approaches to address these complex health issues. Chronic diseases and comorbidities further exacerbate the complexity of treatments, adding pressure on healthcare costs, particularly as the number of elderly patients rises amidst a decreasing number of healthcare providers.

In response to these challenges, the life science industry sees potential to explore innovative health technologies that can enhance patient outcomes and optimize the costs of care. The integration of such technologies in cardiovascular disease management holds promise for delivering more personalized care tailored to individual patient needs.

Join us for a roundtable discussion as we delve into key themes surrounding the utilization of innovative technologies in cardiovascular disease management (treatment adherence, diagnosis or management or prevention):

1. Transitioning to Personalized Care: What are the challenges in moving away from the traditional one-size-fits-all approach in pharma and diagnostics towards a more tailored approach for cardiovascular disease management?

2. Overcoming Barriers to Innovation: How can we navigate complex healthcare systems, inhibiting and innovation-averse incentive systems and outdated decision-making processes to facilitate the early integration of innovative technologies in cardiovascular disease management?

3. Optimizing Collaboration: How can collaboration between MedTech and pharma companies be enhanced to drive innovation in cardiovascular disease management, especially considering the misalignment of traditional funding models with long-term goals?